Abstract：Objective To investigate the clinical effect of Tiotropium Bromide combined with Formoterol inhalation in the treatmentof chronic obstructive pulmonary disease.Methods Sixty patients with chronic obstructive pulmonary disease admitted to our hospital from February 2017 to February 2019 were selected as the research subjects,and they were divided into the control group(30 cases)and the observation group(30 cases)according to the random number table method.Patients in the control group were treated with Tiotropium Bromide alone,and patients in the observation group were given Tiotropium Bromide combined with Formoterol inhalation.The clinical efficacy and incidence of adverse reactions of the two groups of patients were observed,and the lung function(forced expiratory volume in one second[FEV1],forced vital capacity[FVC],FEV1 to FVC ratio[FEV1/FVC]),maximal voluntary ventilation(MVV)],dyspnea scale(MRC)score and 6min walking distance(6MWD)before and after treatmentwere compared between the two groups of patients.Results The total effective rate of treatment in the observation group was higher than that in the control group,and the difference was statistically significant(P＜0.05).The FEV1,FVC,FEV1/FVC,and MVV after treatment in the observation group were higher than those in the control group,and the differences were statistically significant(P＜0.05).The MRC score of patients in the observation group was lower than that in the control group,the 6MWD was farther than that in the control group,and the differences were statistically significant(P＜0.05).No serious adverse reactions occurred during the treatment of the two groups.Conclusion Tiotropium Bromide combined with Formoterol inhalation in the treatment of patients with chronic obstructive pulmonary disease has significant effect,it can increase pulmonary function,improve dyspnea,enhance exercise tolerance,and promote outcome of the disease,which has certain safety.
刘文华. 噻托溴铵联合福莫特罗吸入治疗慢性阻塞性肺疾病的临床效果[J]. 中国当代医药, 2020, 27(9): 37-39转43.
LIU Wen-hua. Clinical effect of Tiotropium Bromide combined with Formoterol inhalation in the treatment of chronic obstructive pulmonary disease. 中国当代医药, 2020, 27(9): 37-39转43.
京公网安备 11010502046607号